n° 94 WHD Insights: TM | Putting the draft revision of China’s Trademark Law under the spotlight

n° 95 WHD Insights: PT | CNIPA clarifies inventiveness assessment of pharmaceutical use claims

n° 30 News: IP | China overhauls drug administration regime through introduction of market exclusivity, data safeguards and registration certificates as tradable assets